Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method
Not Applicable
- Conditions
- Dyspepsia
- Interventions
- Drug: PlaceboDrug: motilitone
- First Posted Date
- 2014-05-30
- Last Posted Date
- 2014-11-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 78
- Registration Number
- NCT02151708
- Locations
- 🇰🇷
Department of Medicine, Samsung Medical Center,Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model
Completed
- Conditions
- Metastatic Cancer
- First Posted Date
- 2014-05-19
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 895
- Registration Number
- NCT02141152
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Perioperative Inflammation and Breast Cancer Outcome
Phase 3
- Conditions
- Breast Neoplasms
- Interventions
- Drug: NSAIDS (ketorolac and ibuprofen)
- First Posted Date
- 2014-05-19
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1568
- Registration Number
- NCT02141139
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)
Completed
- Conditions
- Metastatic Gastrointestinal CancerGenitourinary Cancer
- First Posted Date
- 2014-05-16
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 229
- Registration Number
- NCT02140463
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Clopidogrel Resistance and Embolism in Carotid Artery Stenting
- First Posted Date
- 2014-05-08
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 86
- Registration Number
- NCT02133989
- Locations
- 🇰🇷
Oh Young Bang, Seoul, Korea, Republic of
No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
Phase 2
Completed
- Conditions
- Bronchopulmonary Dysplasia (BPD)
- Interventions
- Drug: Oral ibuprofenDrug: Normal saline
- First Posted Date
- 2014-05-01
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 142
- Registration Number
- NCT02128191
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Oligosecretary Myeloma: Prevalence and Its Clinical Significance
Completed
- Conditions
- Multiple Myeloma
- Interventions
- Other: oligosecretary
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2014-03-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 390
- Registration Number
- NCT02095379
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept
Not Applicable
- Conditions
- Diabetes
- Interventions
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2014-03-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 152
- Registration Number
- NCT02095418
- Locations
- 🇰🇷
Seoul National University, Seoul, Korea, Republic of
🇰🇷Daegu Catholic University Medical Center, Daegu, Korea, Republic of
🇰🇷National Cancer Center, Seoul, Korea, Republic of
Efficacy of Motilitone on Gastric Accommodation in Healthy Adult Patients: Evaluation Using MRI Method
Not Applicable
Completed
- Conditions
- Dyspepsia
- Interventions
- Drug: Placebo (for Motilitone)Drug: Motilitone
- First Posted Date
- 2014-03-19
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT02091635
- Locations
- 🇰🇷
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes
Not Applicable
- Conditions
- Macular Hole With High Myopia (Spherical Equivalent ≤ -6.0 Diopters) or,Large Size Macular Hole (Diameter > 600 Microns) orRecurred or Failed Macular Hole From Previous Surgeryor Chronic Macular Hole (Symptom Duration > 6 Months)
- Interventions
- Procedure: Autologous platelet concentrate
- First Posted Date
- 2014-03-07
- Last Posted Date
- 2014-03-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT02081170
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath